Rituximab maintenance following a rituximab containing chemotherapy significantly prolongs the duration of response in patients with relapsed follicular and mantle cell lymphomas: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
暂无分享,去创建一个
W. Hiddemann | M. Dreyling | M. Gramatzki | R. Forstpointner | H. Böck | M. Unterhalt | J. Seymour | M. Haenel